Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Serotype 2 <i>α</i> 1-Antitrypsin (AAT) Vector in AAT-Deficient AdultsMark Brantly, Terence R. Flotte, Sihong Song et al.|Human Gene Therapy|2006Cited by 175
728. Safety and Bioactivity of rAAV2-hAAT in alpha-1 Antitrypsin-Deficient Patients in a Phase I Clinical TrialMark Brantly, Terence R. Flotte, Terry Spencer et al.|Molecular Therapy|2006Cited by 0
Phase I Trial of Intramuscular Injection of a Recombinant Adeno-associated Virus Serotype 2 ? <sub>1</sub> -Antitrypsin (AAT) Vector in AAT-Deficient AdultsMark Brantly, Terence R. Flotte, L. Terry Spencer et al.|Human Gene Therapy|2006Cited by 0
Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Serotype 2 <i>?</i> <sub>1</sub> -Antitrypsin (AAT) Vector in AAT-Deficient AdultsMark Brantly, Terence R. Flotte, L. Terry Spencer et al.|Human Gene Therapy|2006Cited by 0